Your session is about to expire
β Back to Search
Spectral scan (All participants) for Screening
N/A
Waitlist Available
Led By Rae Lake, MD
Research Sponsored by Ottawa Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Qualifies for COVID-19 testing as per Assessment Site protocol; or Is capable of cooperating with testing
Is clinically stable such that the testing protocol may be completed safely
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediate upon scan
Awards & highlights
Study Summary
In this study, we will use the SpotLight-19 device in patients presenting to a coronavirus disease (COVID-19) Assessment Centre for polymerase chain reaction (PCR) testing. Consenting patients will undergo a Spotlight-19 scan. We will link the scan to PCR results, age, vaccination status, and COVID-19 symptoms in order to calibrate the SpotLight-19 prediction algorithm of a state of COVID-19 infection.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check βYesβ for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediate upon scan
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediate upon scan
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
spectra indicative of COVID-19 infection
Trial Design
1Treatment groups
Experimental Treatment
Group I: Spectral scan (All participants)Experimental Treatment1 Intervention
Fitzpatrick skin assessment.
Fingertip scanned using the SpotLight-19 device. The scan is approximately 10-20 seconds. Participants will not feel any sensation from the device, i.e., no heat, no pain, no cold, no vibration or pressure.
Information collected from the medical record regarding participant age, COVID-19 vaccination status, presence of COVID-19 symptoms, and PCR test result.
Find a Location
Who is running the clinical trial?
Ottawa Hospital Research InstituteLead Sponsor
559 Previous Clinical Trials
2,773,052 Total Patients Enrolled
1 Trials studying Screening
3,536 Patients Enrolled for Screening
ISBRG CorpOTHER
1 Previous Clinical Trials
75 Total Patients Enrolled
Rae Lake, MDPrincipal InvestigatorISBRG Corp
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger